JP2004503501A - イミダゾピリジンおよびイミダゾピリミジン抗ウイルス剤 - Google Patents

イミダゾピリジンおよびイミダゾピリミジン抗ウイルス剤 Download PDF

Info

Publication number
JP2004503501A
JP2004503501A JP2002510088A JP2002510088A JP2004503501A JP 2004503501 A JP2004503501 A JP 2004503501A JP 2002510088 A JP2002510088 A JP 2002510088A JP 2002510088 A JP2002510088 A JP 2002510088A JP 2004503501 A JP2004503501 A JP 2004503501A
Authority
JP
Japan
Prior art keywords
embedded image
nmr
compound
mmol
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002510088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503501A5 (OSRAM
Inventor
クオ−ロン・ユ
リタ・エル・シビエロ
キース・ディ・コムブリンク
ハティス・ベルジン・ガルゲーズ
ニ・シン
シャンドン・ワン
ニコラス・エイ・ミーンウェル
ブライアン・リー・ベナブルズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JP2004503501A publication Critical patent/JP2004503501A/ja
Publication of JP2004503501A5 publication Critical patent/JP2004503501A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2002510088A 2000-06-13 2001-05-08 イミダゾピリジンおよびイミダゾピリミジン抗ウイルス剤 Withdrawn JP2004503501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21144700P 2000-06-13 2000-06-13
US26336301P 2001-01-22 2001-01-22
PCT/US2001/014775 WO2001095910A1 (en) 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents

Publications (2)

Publication Number Publication Date
JP2004503501A true JP2004503501A (ja) 2004-02-05
JP2004503501A5 JP2004503501A5 (OSRAM) 2006-06-01

Family

ID=26906145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510088A Withdrawn JP2004503501A (ja) 2000-06-13 2001-05-08 イミダゾピリジンおよびイミダゾピリミジン抗ウイルス剤

Country Status (20)

Country Link
US (1) US6489338B2 (OSRAM)
EP (1) EP1311268A4 (OSRAM)
JP (1) JP2004503501A (OSRAM)
KR (1) KR20030008151A (OSRAM)
CN (1) CN1436079A (OSRAM)
AR (1) AR029128A1 (OSRAM)
AU (2) AU2001272906B2 (OSRAM)
BR (1) BR0111569A (OSRAM)
CA (1) CA2412327A1 (OSRAM)
CZ (1) CZ20024078A3 (OSRAM)
HU (1) HUP0400766A2 (OSRAM)
IL (1) IL152889A0 (OSRAM)
MX (1) MXPA02012204A (OSRAM)
NO (1) NO20025977L (OSRAM)
NZ (1) NZ523566A (OSRAM)
PE (1) PE20011348A1 (OSRAM)
PL (1) PL360290A1 (OSRAM)
RU (1) RU2003100828A (OSRAM)
UY (1) UY26758A1 (OSRAM)
WO (1) WO2001095910A1 (OSRAM)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546738A (ja) * 2005-06-20 2008-12-25 テイボテク・フアーマシユーチカルズ・リミテツド 呼吸器シンシチウムウイルスに活性をもつ、１−（２−アミノ−３−（置換アルキル）−３ｈ−ベンズイミダゾイルメチル）−３−置換−１，３−ジヒドロ−ベンゾイミダゾル−２−オン
JP2013545785A (ja) * 2010-12-16 2013-12-26 ヤンセン・アールアンドデイ・アイルランド ベンゾイミダゾール呼吸合胞体ウイルス阻害剤
JP2015519386A (ja) * 2012-06-15 2015-07-09 ヤンセン・アールアンドデイ・アイルランド Ｒｓウイルス抗ウイルス薬としての、複素環によって置換された新規１，３−ジヒドロ−２ｈ−ベンゾイミダゾル−２−オン誘導体
JP2015519381A (ja) * 2012-06-11 2015-07-09 ユーシービー バイオファルマ エスピーアールエル Ｔｎｆ−アルファ調節ベンゾイミダゾール
JP2016145236A (ja) * 2010-12-16 2016-08-12 ヤンセン・サイエンシズ・アイルランド・ユーシー 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール
JP2023500213A (ja) * 2019-10-30 2023-01-05 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー ３－ニトロ－ｎ－（２，２，２－トリフルオロエチル）－４－ピリジンアミンの合成
JP2023500214A (ja) * 2019-10-30 2023-01-05 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー ３－（｛５－クロロ－１－［３－（メチルスルホニル）プロピル］－１Ｈ－インドール－２イル｝メチル）－１－（２，２，２－トリフルオロエチル）－１，３－ジヒドロ－２Ｈ－イミダゾ［４，５－ｃ］ピリジン－２－オンの合成

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774134B2 (en) * 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
WO2003049688A2 (en) * 2001-12-10 2003-06-19 Bristol-Myers Squibb Company Bis hydrochloride monohydrate salt of rsv fusion inhibitor
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
WO2004043913A2 (en) * 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
WO2005016275A2 (en) * 2003-08-05 2005-02-24 3M Innovative Properties Company Formulations containing an immune response modifier
EP1682547B1 (en) 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
NZ551468A (en) 2003-12-24 2010-05-28 Biota Scient Management Polycyclic agents for the treatment of respiratory syncytial virus infections
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
CN101027303A (zh) 2004-07-27 2007-08-29 吉里德科学公司 咪唑并[4，5－d]嘧啶类、其应用和制备方法
CN101203507B (zh) 2005-06-20 2012-05-23 泰博特克药品有限公司 2-取代的苯并咪唑
JP5094716B2 (ja) 2005-06-20 2012-12-12 テイボテク・フアーマシユーチカルズ ヘテロシクリルアミノアルキル置換ベンズイミダゾール
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
WO2009084544A1 (ja) * 2007-12-27 2009-07-09 Idemitsu Kosan Co., Ltd. 含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
US20100278835A1 (en) 2009-03-10 2010-11-04 Astrazeneca Uk Limited Novel compounds 660
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
WO2011115150A1 (ja) * 2010-03-18 2011-09-22 興和株式会社 ベンゾチアジン化合物の製造方法
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI541241B (zh) * 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
CN103860538B (zh) * 2011-03-23 2016-03-02 上海市第一人民医院 靶向人La蛋白的先导化合物及其在制备抗乙型肝炎病毒的药物中的用途
CA2873916A1 (en) * 2012-06-15 2013-12-19 Janssen R&D Ireland 4-substituted 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antivira agents
JP2015523350A (ja) * 2012-06-15 2015-08-13 ヤンセン・アールアンドデイ・アイルランド Ｒｓウイルス抗ウイルス薬としての、ベンゾイミダゾールによって置換された新規１，３−ジヒドロ−２ｈ−ベンゾイミダゾル−２−オン誘導体
WO2013186335A1 (en) * 2012-06-15 2013-12-19 Janssen R&D Ireland 1,3 -dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
MY172021A (en) * 2012-10-16 2019-11-12 Janssen Sciences Ireland Uc Rsv antiviral compounds
JP2016145155A (ja) * 2013-04-30 2016-08-12 日本農薬株式会社 フタルアミド誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法
BR112016009757A8 (pt) * 2013-10-29 2018-01-30 Medivir Ab “inibidores do vírus sincicial respiratório com base em quinazolina”
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
CA3008653A1 (en) * 2015-10-14 2017-04-20 Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. Bruton's tyrosine kinase inhibitors
WO2019046364A1 (en) * 2017-08-29 2019-03-07 Emory University INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) REPLICATION AND USES THEREOF
EP4165034A1 (en) 2020-06-11 2023-04-19 Janssen Sciences Ireland Unlimited Company Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same
WO2022184606A1 (en) * 2021-03-01 2022-09-09 Janssen Sciences Ireland Unlimited Company Synthesis of rilematovir
JP2025502943A (ja) * 2022-01-28 2025-01-30 インシリコ メディシン アイピー リミテッド エクトヌクレオチドピロホスファターゼ－ホスホジエステラーゼ１（ｅｎｐｐ１）阻害剤およびその使用
WO2025026383A1 (en) * 2023-08-02 2025-02-06 Insilico Medicine Ip Limited Crytsalline forms of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
DK154078C (da) 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
BR9700939A (pt) 1996-02-13 1998-09-01 American Cyanamid Co Compostos aniônicos contendo traiazina úteis como agentes antivirais
BR9908522A (pt) 1998-01-29 2001-10-02 Viropharma Inc Composto, pró-droga, intermediário para a preparação de um composto, composição farmacêutica, processos para tratar e prevenir infecção por pneumovìrus, para tratar células em cultura, para tratar materiais biológicos, e, para preparar um composto
CA2338147A1 (en) 1998-07-20 2000-02-03 Kuo-Long Yu Substituted benzimidazole antiviral agents
HRP20010934A2 (en) 1999-06-28 2003-06-30 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546738A (ja) * 2005-06-20 2008-12-25 テイボテク・フアーマシユーチカルズ・リミテツド 呼吸器シンシチウムウイルスに活性をもつ、１−（２−アミノ−３−（置換アルキル）−３ｈ−ベンズイミダゾイルメチル）−３−置換−１，３−ジヒドロ−ベンゾイミダゾル−２−オン
JP2013545785A (ja) * 2010-12-16 2013-12-26 ヤンセン・アールアンドデイ・アイルランド ベンゾイミダゾール呼吸合胞体ウイルス阻害剤
JP2016145236A (ja) * 2010-12-16 2016-08-12 ヤンセン・サイエンシズ・アイルランド・ユーシー 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール
JP2015519381A (ja) * 2012-06-11 2015-07-09 ユーシービー バイオファルマ エスピーアールエル Ｔｎｆ−アルファ調節ベンゾイミダゾール
JP2015519386A (ja) * 2012-06-15 2015-07-09 ヤンセン・アールアンドデイ・アイルランド Ｒｓウイルス抗ウイルス薬としての、複素環によって置換された新規１，３−ジヒドロ−２ｈ−ベンゾイミダゾル−２−オン誘導体
JP2023500213A (ja) * 2019-10-30 2023-01-05 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー ３－ニトロ－ｎ－（２，２，２－トリフルオロエチル）－４－ピリジンアミンの合成
JP2023500214A (ja) * 2019-10-30 2023-01-05 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー ３－（｛５－クロロ－１－［３－（メチルスルホニル）プロピル］－１Ｈ－インドール－２イル｝メチル）－１－（２，２，２－トリフルオロエチル）－１，３－ジヒドロ－２Ｈ－イミダゾ［４，５－ｃ］ピリジン－２－オンの合成

Also Published As

Publication number Publication date
AU7290601A (en) 2001-12-24
NO20025977D0 (no) 2002-12-12
RU2003100828A (ru) 2004-06-27
KR20030008151A (ko) 2003-01-24
AR029128A1 (es) 2003-06-04
UY26758A1 (es) 2002-01-31
CN1436079A (zh) 2003-08-13
WO2001095910A1 (en) 2001-12-20
EP1311268A4 (en) 2004-06-30
BR0111569A (pt) 2003-04-29
NO20025977L (no) 2003-01-29
PE20011348A1 (es) 2002-02-07
HUP0400766A2 (hu) 2004-07-28
IL152889A0 (en) 2003-06-24
US6489338B2 (en) 2002-12-03
NZ523566A (en) 2004-08-27
CA2412327A1 (en) 2001-12-20
US20020016309A1 (en) 2002-02-07
MXPA02012204A (es) 2003-10-15
AU2001272906B2 (en) 2004-08-26
PL360290A1 (en) 2004-09-06
EP1311268A1 (en) 2003-05-21
CZ20024078A3 (cs) 2003-08-13

Similar Documents

Publication Publication Date Title
US6489338B2 (en) Imidazopyridine and imidazopyrimidine antiviral agents
AU2001272906A1 (en) Imidazopyridine and imidazopyrimidine antiviral agents
CA2903215C (en) Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
CN101351466B (zh) Janus激酶3的杂环抑制剂
JP5227304B2 (ja) 新規なヒドロキサム酸誘導体
AU2003214503B2 (en) Tropane derivatives as CCR5 modulators
AU2019416589A1 (en) Heterocyclic compound intermediate, preparation method therefor and application thereof
EP2123651A1 (en) Condensed pyridine compound
AU2003300902A1 (en) Piperidine derivatives as CCR5 antagonists
CA3053484A1 (en) Aminotriazolopyridines as kinase inhibitors
CA2943874A1 (en) Substituted spirocyclic inhibitors of autotaxin
JP2009522232A (ja) Ｐｄｆインヒビター
EA027247B1 (ru) Новые производные пиридина
AU2011343258A1 (en) Azabenzimidazoles as respiratory syncytial virus antiviral agents
EP0925299B1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
JP2025505230A (ja) 二環式ヘテロアリール化合物およびその使用
CA3059954A1 (en) Substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof
CN115698011B (zh) Pb2抑制剂及其制备方法和用途
HK1123303B (en) Heterocyclic janus kinase 3 inhibitors
JP2023550798A (ja) 抗コリン剤
WO2010025436A2 (en) Nitrogen and sulfur-containing heterocycle derivatives
ZA200210104B (en) Imidazopyridine and imidazopyrimidine antiviral agents.
MX2008000621A (es) Inhibidores heterociclicos de cinasa 3 de janus.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060405

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060405

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20061030